Format
Sort by

Send to:

Choose Destination

Results: 3

1.

Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study.

Hopewell JC, Parish S, Offer A, Link E, Clarke R, Lathrop M, Armitage J, Collins R; MRC/BHF Heart Protection Study Collaborative Group.

Eur Heart J. 2013 Apr;34(13):982-92. doi: 10.1093/eurheartj/ehs344. Epub 2012 Oct 24.

2.

No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study.

Hopewell JC, Parish S, Clarke R, Armitage J, Bowman L, Hager J, Lathrop M, Collins R; MRC/BHF Heart Protection Study Collaborative Group.

J Am Coll Cardiol. 2011 May 17;57(20):2000-7. doi: 10.1016/j.jacc.2011.02.015. Epub 2011 Mar 31.

3.

Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20,536 high-risk people.

MRC/BHF Heart Protection Study Collaborative Group, Armitage J, Bowman L, Collins R, Parish S, Tobert J.

BMC Clin Pharmacol. 2009 Mar 31;9:6. doi: 10.1186/1472-6904-9-6.

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk